No black box warning on record for Betoptic S

As of the latest FDA labeling reviewed, Betoptic S (BETAXOLOL HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Betoptic S medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Systemic Absorption : Same adverse reactions found with systemic administration of beta-adrenergic receptor inhibitors may occur with topical ophthalmic administration. ( 5.1 ) Cardiac Failure : Discontinue treatment at the first signs of cardiac failure. ( 5.2 ) Diabetes Mellitus : Beta-adrenergic receptor inhibitors may mask the signs and symptoms of acute hypoglycemia

No black box warning on record for Betoptic S

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Systemic Absorption : Same adverse reactions found with systemic administration of beta-adrenergic receptor inhibitors may occur with topical ophthalmic administration. ( 5.1 ) Cardiac Failure : Discontinue treatment at the first signs of cardiac failure. ( 5.2 ) Diabetes Mellitus : Beta-adrenergic receptor inhibitors may mask the signs and symptoms of acute hypoglycemia

Betoptic S Black Box Warning

No black box warning on record for Betoptic S

Other warnings & precautions

Betoptic S Black Box Warning

No black box warning on record for Betoptic S

Other warnings & precautions